Belgian scaleup Oncomfort raises €10 million to further develop its “Digital Sedation” through virtual reality

Today Oncomfort, a Belgian inventor of and leader in Digital Sedation (a new method for relieving patient pain and anxiety without medication) has today announced the completion of a €10 million Series A funding round, co-led by two prominent institutional investors: Debiopharm and Crédit Mutuel Innovation. Oncomfort plans to use this investment to further develop…

This content is for members only. Visit the site and log in/register to read.

EU-Startups

Automotive intelligence startup Acerta Analytics closes €5.8M Series A funding to expand further in Europe

Founded in 2017 by Greta Cutulenco, Jean-Christophe Petkovich, and Sebastian Fischmeister, Acerta began with research on automated pattern recognition and anomaly detection in the world-renowned engineering laboratories at the University of Waterloo.

Recently, Acerta Analytics has raised $ 7 million (approx €5.8 million)in Series A funding led by OMERS Ventures, with additional participation from M12 – Microsoft’s venture fund, StandUp Ventures, Radical Ventures, EDC, and Techstars. 

This funding will enable the company to launch into new markets, expand its team, and extend the capabilities of its platform to generate insights into automotive production and vehicle data. 

Generated 94 petabytes (PB) of data in 2019

Since the vehicles are becoming more connected and instrumented, it generates more data. According to Acerta, the connected vehicles generated approximately 94 petabytes (PB) of data in 2019, while automotive manufacturing generated nearly ten times that amount. 

As this immense volume of vehicle data increases, automotive engineers require new tools to manage and extract information from it. Acerta’s platform uses artificial intelligence to help automakers leverage their data for insights into vehicle assembly or on-road performance.

“Every automotive engineer has dealt with issues during assembly or testing, but few can use their production data to predict when and where those issues will occur and prevent them,” said Greta Cutulenco, CEO and Co-Founder of Acerta. “That’s why we’ve focused on providing predictive analytics to our customers to help them ensure vehicle quality, safety, and reliability.”

Increase in demand

The COVID-19 pandemic also creates huge pressure on automakers to digitise their processes, find new ways to reduce costs, and increase production efficiency. As a result, Acerta has experienced an increase in demand for its solutions. The company offers automotive engineers the tools to optimise quality, safety, and reliability throughout the entire product life cycle, from the assembly line to the finish line.

“Beyond digitization, the global pandemic has also forced vehicle manufacturers to focus on cost containment,” Cutulenco continued. “By identifying the earliest indicators of future product failures, our platforms are helping automakers reduce their scrap and rework rates and increase first time yield.”

Expanding to Europe and Japan

Acerta currently operates in Canada and the United States in North America, as well as Europe and Japan, with plans to expand further into the European and Japanese markets within the next year.

“Artificial intelligence has already played a huge role in stimulating innovation in the automotive industry, and it will continue to do so for many years to come,” said Brian Kobus, Partner, OMERS Ventures. “We’ve entered a new phase in the world of transportation, and Acerta is in a unique position to empower automakers around the world by enabling them to harness the power of their data to deliver valuable insights, drive ROI, and ultimately make better decisions for their business and customers.”

Main image credits: Acerta Analytics

The post Automotive intelligence startup Acerta Analytics closes €5.8M Series A funding to expand further in Europe appeared first on Silicon Canals .

Startups – Silicon Canals

Zürich-based online market Farmy secures €9.2 million for further expansion

The rapidly growing Swiss online market Farmy has secured around €9.2 million in a further financing round from impact investing fund Triodos Organic Growth Fund and other investors.

Founded in 2014, Farmy is an online market for transparent and sustainable weekly shopping, directly from the producer. Farmy offers over 12,500 mainly organic hand-picked products from more than 1,000 authentic producers, and, thanks to its smart logistics and own fleet and e-mobiles, delivers these goods incomparably fresh, emission-reduced and time-saving directly to users’ front doors – with its own fleet of e-mobiles. In the metropolitan regions of Zurich and Lake Geneva delivery is even free of charge. Products include fruits and vegetables, cheeses from Swiss dairies, meat, delicacies and sweet temptations from real bakers and confectioners, as well as pantry and drugstore items. 

In the first half of 2020, Farmy increased its sales by 160% compared to the previous year. With sales of around €10.6 million in this period, the young company further strengthened its position as the third largest online food shop in Switzerland.

During this round, Farmy added Triodos Organic Growth Fund as an investor. The fund provides long-term mission-aligned private equity to European frontrunners in the sustainable food sector and will act as the new lead investor at Farmy. “Farmy has been able to build a very impressive company with a strong sustainability impact in recent years. Farmy sets new standards in the regional food supply chain and we are looking forward to actively contribute to the further growth and strategic development of Farmy ”, states Isabelle Laurencin, Principal Investment Manager from Triodos Organic Growth Fund.

Farmy also gained several private investors from new and existing investor circles to secure the financing of the company in the future. One of these private investors is Thomas Harttung, co-founder of Aarstiderne, a Danish online provider of organic meal-box solutions.

Co-founder and co-CEO of Farmy, Tobias Schubert commented: “As a strongly mission-driven company, we are proud to be backed by such a highly respected and especially sustainable institutional investor like Triodos Organic Growth Fund. We are fully convinced that together we will create much more value for all stakeholders of Farmy focusing on further growth by following our mission of a greener way of eating.”

In particular, Farmy will use the investment to expand its own fleet of electric vehicles as well as the delivery areas, the warehouse and further investment in its in-house IT alongside marketing efforts. Farmy is increasingly acting as an IT service provider, enabling food producers, associations as well as offline food retailers to digitalise their offering.

Farmy not only provides the storefronts but, as IT service provider, also the systems behind them to manage the fulfilment and delivery of fresh food along the entire value chain. The first customers to use these services are the producer Jucker Farm and the major Swiss organic label “Bio Suisse”. Roman Hartmann, Co-founder and co-CEO of Farmy, Tobias Schubert, explained more: “Over the last 6 years we have become an expert in e-food and built a unique IT infrastructure. Even though the customers’ willingness to shop groceries online is growing rapidly – boosted additionally by Covid-19 – there is an extreme lack of e-food expertise in the market.” Strategically, Farmy will continue to grow this area as a second mainstay.

EU-Startups

IT minister launches ‘Chunauti’ a programme to further boost startups, software product – The Hans India

IT minister launches ‘Chunauti’ a programme to further boost startups, software product  The Hans India
“startups when:1d” – Google News

Healthtech startup Castor lands €10.1 million to further support COVID-19 research

Amsterdam and Hoboken-based Castor a leading provider of clinical trial technology that automates the research process, has announced that it has raised around €10.1 million in funding. The round was led by Two Sigma Ventures with participation from Hambrecht Ducera Growth Ventures and existing investor INKEF Capital. Castor will use the funding to further invest in enabling patient-centric, data-powered clinical trials.

Founded in 2011, Castor is a cloud-based clinical data platform that simplifies the clinical trial process, from recruitment to analysis, for researchers globally. It’s used by more than 50,000 users across academia and commercial research, powering more than 4,000 studies with more than 2 million enrolled patients across 90 countries. 192 medical device, biotech, and pharmaceutical companies and contract research organizations (CROs) are using Castor’s platform.

Castor made its platform freely available for all non-profit COVID-19 research starting in February. They are one of the only providers that can enable large-scale decentralized trials to accelerate the work of researchers who are trying to combat the disease. More than 200 COVID-19 projects across 33 countries are currently running on the platform, including the World Health Organization’s global Solidarity trial. Through their platform, more than 10,000,000 COVID-19 data points have been captured and 50 COVID-19 projects have committed to making their data reusable and accessible to others, so that the world can collaborate effectively to stop the disease.

“There are three key challenges that need to be addressed in the clinical trial space: making research more patient-centric, maximizing the impact of data on human lives, and better addressing the needs of underserved communities,” said Derk Arts, MD, PhD, CEO and founder of Castor. 

“With this new investment, we will be able to make significant progress in all three areas by continuing to deliver user-friendly, accessible technology that can support remote trials, while ensuring machine-readable output that allows for trial automation and data reuse. In the next 18 months we intend to support our customers with patient recruitment and synthetic control arms, through better use of their data. We are excited to partner with Two Sigma Ventures, who bring extensive experience in leveraging the power of data and AI to disrupt incumbent industries.”

Castor will use this new funding to further strengthen its support for patient-centric, remote trials and to enable customers to maximize value from existing and newly generated data throughout the clinical trial process. 

Villi Iltchev, Partner at Two Sigma Ventures, commented: “We believe that the life sciences industry is lacking a comprehensive and scalable solution for recruiting candidates for clinical trials, managing the research process, and effectively harnessing the vast amounts of data those clinical trials produce to drive medical breakthroughs. Castor’s technology and team have the ability to meet all of those needs as evidenced by their customer demand and ability to enter new segments. It is our belief that their vision to enable AI and automation in clinical trials will quickly change the face of clinical research.”

EU-Startups

[Zebra in Business Wire] Canon Medical Systems USA, Inc. Partners With Zebra Medical Vision to Further Expand AI Offerings

Zebra-Med’s AI1™ technology provides cloud-based analysis of images through FDA-cleared AI solutions, trained on millions of patient scans to triage acute medical conditions, detect incidental findings and stratify risk. This partnership with Canon Medical Systems USA, Inc. marks the introduction of Zebra-Med’s solution into the modality space, bringing AI analysis closer to the point of care.

Read more here.

The post [Zebra in Business Wire] Canon Medical Systems USA, Inc. Partners With Zebra Medical Vision to Further Expand AI Offerings appeared first on OurCrowd Blog.

OurCrowd Blog

[Zebra in Yahoo News] Canon Medical Systems USA, Inc. Partners With Zebra Medical Vision to Further Expand AI Offerings

Zebra-Med’s AI1™ technology provides cloud-based analysis of images through FDA-cleared AI solutions, trained on millions of patient scans to triage acute medical conditions, detect incidental findings and stratify risk. This partnership with Canon Medical Systems USA, Inc. marks the introduction of Zebra-Med’s solution into the modality space, bringing AI analysis closer to the point of care.

Read more here.

The post [Zebra in Yahoo News] Canon Medical Systems USA, Inc. Partners With Zebra Medical Vision to Further Expand AI Offerings appeared first on OurCrowd Blog.

OurCrowd Blog